Protear

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Protear

Property Description
Active ingredient Povidone-Iodine (PVP-I)
Form Otic Solution (Ear Drops)
Pharmacological Class Antiseptic and Broad-Spectrum Antimicrobial Agent
General Purpose Cleansing and sanitation of the external ear canal
Origin Synthetic Complex (Iodophor)

Protear: Definition, Class, and Active Ingredient

Protear is an otic solution, commonly known as ear drops, formulated to function as a powerful, broad-spectrum antimicrobial and localized antiseptic agent. Its identity is defined by its sole active pharmaceutical component: Povidone-Iodine (PVP-I). Povidone-Iodine is categorized within the pharmacological class of antiseptics and disinfectants. The inclusion of this agent confirms its established role in general antisepsis, a property recognized for its rapid onset of action against microbial threats. As an antiseptic, this medicine is intended for topical application to the living tissue of the external ear canal to significantly reduce the population of diverse infectious microorganisms. The choice of the single-ingredient Povidone-Iodine complex ensures targeted and verifiable germicidal action.

Composition, Form, and Synthetic Origin

The preparation is supplied as a solution specifically for otic administration, utilizing Povidone-Iodine, a synthetic chemical complex, as its core active agent. Povidone-Iodine is classified as an iodophor, a stabilized substance where the germicidal agent, iodine, is chemically bound to the polymer polyvinylpyrrolidone. This complexation allows the gradual and controlled release of free iodine, the component responsible for the microbial destruction, while notably reducing the potential for localized irritation. The formulation uses an aqueous or water-based vehicle and stabilizers, distinguishing it from historical alcohol-based iodine solutions and optimizing the stability of the PVP-I complex for application in the ear, a feature specifically designed for the sensitive environment of the auditory canal.

General Purpose of the Antiseptic Action

The general purpose of Protear is to leverage its potent, non-selective germicidal capabilities to achieve comprehensive cleansing and sanitation of the ear canal. Its function is based on the chemical principle of oxidation, which rapidly and extensively neutralizes essential microbial components. The compound is designed for effectiveness against a wide array of pathogens. The aim of applying this antiseptic action is to dramatically reduce the microbial load, encompassing various bacteria, fungi, viruses, and spores, thereby supporting an environment conducive to alleviating general discomfort associated with minor microbial presences in the ear.

What side effects are possible with Protear?

Possible Side Effects and Safety Information for Protear

The safety profile for Protear includes both commonly reported reactions and serious, clinically significant adverse events documented in official regulatory sources (such as the FDA and EMA).

Adverse Reactions by Frequency

Adverse reactions are classified according to standard frequency guidelines (e.g., ICH/EMA): Very Common (ge 1/10), Common (ge 1/100 to < 1/10), and Uncommon (ge 1/1,000 to < 1/100).

Classification System-Organ Class Involved Examples of Reported Reactions
Very Common Nervous System; Gastrointestinal Headache; Nausea, Diarrhea
Common General Disorders; Hepatobiliary Fatigue; Increased liver enzymes (ALT/AST)
Uncommon Immune System; Skin and Subcutaneous Hypersensitivity reactions (e.g., angioedema); Severe cutaneous adverse reactions (SCAR)

Serious and Significant Safety Risks

Hepatotoxicity (severe liver injury), including cases requiring hospitalization, is a major documented risk. The incidence of elevated liver enzymes is noted to be dose-dependent.

Severe Cutaneous Adverse Reactions (SCAR), such as Stevens-Johnson Syndrome (SJS), and Acute Hypersensitivity Reactions (e.g., anaphylaxis) are serious, uncommon, immunological risks that necessitate immediate medical intervention.

Safety Restrictions and Monitoring

Protear is formally contraindicated in patients who have a known history of hypersensitivity to the drug or in patients with severe hepatic impairment.

Regulatory documentation mandates the requirement for baseline and periodic monitoring of liver function tests (LFTs) throughout treatment to detect signs of potential hepatotoxicity. Caution is specifically advised when used in patients with renal or hepatic impairment due to the potential for altered drug exposure or exacerbation of liver issues. Discontinuation is typically required if liver enzyme elevations exceed predefined thresholds or if SCAR is suspected.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with Protear (Povidone-Iodine otic solution) is associated with the risk of systemic toxicity, which primarily arises from accidental ingestion of the solution or excessive systemic absorption. Officially documented Systemic Toxicity Manifestations include gastrointestinal symptoms such as Vomiting, Diarrhea, and Abdominal pain, as well as signs like a Metallic taste in the mouth and excessive salivation.

Regulators have documented that severe systemic exposure may lead to Life-Threatening Metabolic and Organ Failure. Officially stated outcomes include the development of Acute Renal Failure, severe Metabolic Acidosis, and Circulatory collapse. Endocrine effects, such as the induction of Hypo- or Hyperthyroidism, are also documented, particularly in patients with existing thyroid conditions.

Mandatory Emergency Action is required immediately in any case of suspected overdose or accidental ingestion. The official guidance is to seek immediate medical attention or contact emergency services. Because no specific antidote is known, the prescribed clinical approach is Symptomatic and Supportive Treatment. This requires continuous intensive medical monitoring of the patient's vital signs, renal function, and electrolyte balance until stability is achieved.

Therapeutic Uses of Protear

Uses and Indications

Protear is an ophthalmic solution formulated to provide relief from symptoms associated with ocular surface disorders. Its primary application is the management of dry eye syndrome and the protection of the corneal epithelium.

Primary Applications

  • Dry Eye Syndrome: It is used to alleviate dryness, grittiness, and burning sensations caused by insufficient tear production or rapid tear evaporation.
  • Ocular Lubrication: The solution acts as a substitute for natural tears, enhancing the stability of the precorneal tear film.
  • Environmental Protection: It helps shield the surface of the eye from external irritants such as wind, smoke, dust, and prolonged screen use.
  • Post-Surgical Support: It may be used to maintain moisture on the ocular surface during the recovery period following certain ophthalmic procedures.

Therapeutic Benefits

The formulation is designed to improve patient comfort by addressing the physical discomfort associated with an unstable tear film.

Corneal Hydration

By supplementing the aqueous layer of the tear film, the solution ensures that the cornea remains adequately hydrated. This hydration is essential for maintaining the clarity of the ocular surface and preventing localized irritation.

Symptom Management

Protear helps reduce the friction between the eyelid and the globe of the eye. This mechanical lubrication minimizes the sensation of a foreign body in the eye and reduces redness related to dryness.

Sustained Relief

The viscoelastic properties of the active ingredients allow the solution to remain on the eye for an extended period, providing prolonged moisture compared to standard saline drops. This helps stabilize the tear film and supports the natural healing processes of the ocular epithelium.

Eligibility and Restrictions for Use

The eligibility to use Protear is strictly defined by regulatory documents, which establish clear criteria for inclusion and exclusion based on patient characteristics and pre-existing conditions.

Contraindications (Prohibited Use)

Individuals must not use Protear if they have a known hypersensitivity or severe allergic reaction to the active substance or to any of the product's inactive ingredients. Regulatory labeling dictates that this is an absolute exclusion criterion.

Use in Specific Populations

Population Group Regulatory Status
Pediatric Use (e.g., <18 years) Not Established. Safety and effectiveness are typically not established in this age group due to insufficient clinical data.
Organ Impairment Conditional Use. Patients with severe hepatic impairment or renal impairment are often restricted or prohibited from use. Moderate impairment may require special caution or monitoring.
Pregnancy/Lactation Status documented. The label provides a Risk Summary for use during pregnancy and a statement on whether the drug is excreted in human milk, often advising use is not recommended unless necessary.

Use is generally allowed for adults who do not meet any formal exclusion criteria, but the use is constrained by these official limitations and mandatory restrictions.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Protear's official interaction profile is defined by two primary pharmacokinetic effects documented in regulatory sources: its action on gastric pH and its inhibition of the CYP2C19 enzyme. These interactions lead to specific regulatory constraints for co-administration with various medicinal products.

Co-administration with Rilpivirine-containing products is formally documented as contraindicated because the pH elevation reduces Rilvirine plasma exposure. The medicine is documented as a CYP2C19 inhibitor, which can increase the systemic concentrations of co-administered CYP2C19 substrates, such as Diazepam and Warfarin. Conversely, Protear causes a reduction in the exposure of other pH-dependent drugs, including HIV antivirals like Atazanavir and certain azole antifungals.

Absorption of medicines like Ketoconazole and iron salts is compromised, requiring separation of administration to maintain the bioavailability of the co-administered drug. The label notes that Protear can increase the exposure of Tacrolimus, necessitating therapeutic drug monitoring. Furthermore, interactions with enzyme inducers, such as the herbal product St. John’s Wort, are documented to reduce Protear's own systemic exposure. Individuals classified as CYP2C19 Poor Metabolizers exhibit altered pharmacokinetics, which affects the magnitude of these documented interactions.

Mechanism of Action

How Protear Works


Non-Selective Molecular Oxidation and Destruction

The active ingredient, Povidone-Iodine (PVP-I), relies on a non-selective chemical process of oxidation and iodination by releasing free iodine ( I2). This free iodine rapidly targets and modifies essential microbial proteins and lipids by reacting with residues like sulfhydryl ( -SH) groups, causing their immediate denaturation and the failure of all structural and enzymatic function. This action is the core mechanism that drives the drug's germicidal activity.


Metabolic Arrest and Functional Collapse

The molecular damage initiates a swift and irreversible mechanistic cascade where the metabolic pathways of the microorganism, particularly cellular respiration, are instantly shut down. The compromise of vital enzyme function and cell membrane integrity results in the rapid microbicidal action (cell death). This mechanism produces the resulting physiological effect of a reduction in the local microbial load on the application site.


Mechanistic Constraint by Organic Load

While the mechanism is chemically forceful, its action is subject to a limitation where free iodine is chemically consumed by non-target organic materials (e.g., proteins, pus, cellular debris) at the site of application. This scavenging effect reduces the concentration of the active agent available to attack the microorganisms, which can lead to a diminished rate of germicidal activity in environments with high organic contamination.

Dosage and Administration Information

How to Use Protear

Protear (Omeprazole) is administered exclusively via the oral route as a delayed-release formulation, which is essential for protecting the active ingredient from degradation by stomach acid. General principles of use include the schedule, dose, and specific administration conditions.


Official Administration Guidelines

Feature Official Label Instruction
Dosing Schedule Most regimens require once-daily administration. For pathological hypersecretory conditions, daily doses up to 360 mg may be administered in divided doses.
Timing in Relation to Meals Administration must occur before eating, typically in the morning.
Form Handling The delayed-release capsules must be swallowed whole and must not be crushed or chewed to preserve the special coating.
Alternative Intake If necessary, the capsule's pellets can be mixed with a small amount of applesauce and swallowed immediately.

Standard Dosing and Duration

Standard adult dosing for symptomatic conditions and the maintenance of healing of Erosive Esophagitis is typically 20 mg once daily. The typical course of treatment for active ulcers or Erosive Esophagitis ranges from 4 to 8 weeks. In specific populations, such as patients with hepatic impairment, a dose reduction to 10 mg once daily may be recommended for maintenance therapy. Pediatric use requires weight-based dosing and is not universally the same as the adult regimen. These requirements establish the standardized administration protocol for use.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Protear

This section summarizes the types of research and the study populations involved in the clinical evaluation of Povidone-Iodine (PVP-I) for otic use. This information is drawn from official scientific literature and public scientific assessments to provide context, without offering personal medical advice or making claims about guaranteed results.


Evidence for Use as a Topical Antiseptic and Cleanser

The active ingredient in Protear, Povidone-Iodine, was studied for its properties as a broad-spectrum antiseptic. This is supported primarily by laboratory studies (in vitro time-kill assays) that research how the compound inactivates various microorganisms, including bacteria, fungi, and viruses, often within short time frames.

Studies report patterns related to rapid and broad germicidal activity across a diverse range of pathogens. Research has examined Povidone-Iodine's action against antibiotic-resistant organisms, and findings suggest a pattern of low resistance development. These fundamental findings contribute to the broader evidence landscape where the ingredient was studied for general antisepsis and sanitation.


Evidence for Symptomatic Management of Minor External Ear Discomfort

Research has explored the use of Povidone-Iodine otic solutions in the context of minor external ear discomfort by using pilot randomized controlled trials (RCTs) and comparative clinical trials. These studies were evaluated in research exploring how symptoms change over time in populations presenting with patient-reported outcomes describing perceived discomfort.

Studies report how symptoms evolved in the observed populations over defined time intervals. Low-certainty evidence has been observed in some studies to explore patterns related to outcomes reflecting daily functioning, such as ear discharge. However, the evidence is limited in this area due to modest sample sizes and limited information for long-term outcomes.


Long-Term Evidence and Research Gaps

Most clinical research related to Protear's use for general antiseptic action focuses on short-term outcomes that capture phases of heightened symptom activity. Follow-up in these trials is generally limited to the duration of the acute episode, monitoring short-term symptom changes.

What remains uncertain is the research context for using high concentrations when the eardrum is compromised, as the evidence base for this specific scenario relies on animal models or case reports, and comparative evidence is lacking from controlled human trials. The long-term effects are not fully established regarding the potential consequences of repeated or extended use.

Key Studies & References Label: POVIDONE-IODINE TOPICAL ANTISEPTIC - povidone-iodine solution (FDA Monograph/DailyMed)

Frequently Asked Questions (FAQ)

Common questions about Protear (FAQ)

Q: How long does it typically take before I start noticing the effects of Protear?

A: According to official product information, the mechanism that reduces acid production begins working rapidly. However, the onset of noticeable symptom relief may vary, but full effects are often seen after a few days of consistent use.

Q: Is Protear considered a high-risk medication?

A: Regulatory documents list the drug's established risk and benefit profile for its approved uses. Official warnings highlight that, like many medications, Protear carries risks for rare but serious events, such as severe liver injury (hepatotoxicity) and severe skin reactions, which is why monitoring is recommended.

Q: Are there any specific foods or drinks that should be avoided while taking Protear?

A: Official prescribing information advises that the medicine is typically taken before eating to help it work correctly. Generally, official drug interaction sections do not list specific foods or non-alcoholic beverages as prohibited interactions.

Q: Is Protear safe to use during pregnancy, according to official sources?

A: Regulatory documents describe the known risks for use during pregnancy. They indicate that a thorough assessment of potential benefits versus potential risks to the fetus is necessary before use.

Q: Is Protear gluten-free or suitable for people with allergies?

A: Official information lists all the active and inactive ingredients in the medication. The drug is generally contraindicated (prohibited) for individuals with known hypersensitivity or allergy to the active ingredients or any component of the formulation.

Q: How is the safety profile of Protear generally described by regulators?

A: The safety profile is carefully described by regulators. It includes both very common, mild effects like headache and nausea, and details on rare, serious adverse reactions that require professional management, such as the need for liver function monitoring.

Q: What is the current scientific consensus on Protear's effectiveness?

A: Regulatory approval by national bodies like the FDA and EMA is granted based on comprehensive clinical studies. These studies supported the determination that the drug is effective for its stated, approved medical indications.

Q: Does Protear have a generic version available?

A: Yes, official sources track the availability of pharmaceutical products. This medication is available in both its original brand-name form and under several generic equivalents.

Q: Is Protear known to cause weight gain or loss?

A: Changes in body weight are not listed among the common side effects described in regulatory documents. Weight change may be mentioned in post-marketing reports as a rare reaction where the incidence is not precisely known.

Q: Can Protear be taken with other pain relievers like ibuprofen?

A: Official drug interaction lists specify which medications have known conflicts. If the interaction is not specifically listed on the label, the combination is often considered acceptable. However, regulatory bodies encourage reviewing all medication combinations with a professional.

Q: Is it necessary to take Protear at the exact same time every day?

A: Regulatory guidance specifies that the medicine should be taken once daily and before a meal. The importance of maintaining the schedule is to support steady therapeutic effects, but specific timing should be determined by a healthcare provider.

Q: What happens if I accidentally miss a dose of Protear?

A: Official patient labeling includes guidance for managing a missed dose. This often involves instruction on when to take the missed dose or when to skip it to resume the regular schedule. Specific instructions are found in the package leaflet.

Q: Can Protear affect my ability to drive or operate machinery?

A: Official product information cautions that side effects such as dizziness or blurred vision may occur in some individuals. The label suggests using caution with these activities until an individual is aware of how the medicine affects them.

Q: Is it true that Protear can cause sleep disturbances?

A: Yes, official adverse reaction reports list insomnia (difficulty sleeping) in the uncommon categories for this medication.

Q: Can Protear be used by elderly patients?

A: Regulatory documents include specific sections addressing use in geriatric populations. They often state that no routine dose adjustment is needed for older adult patients, although the elderly may sometimes exhibit increased sensitivity to side effects.

Q: What if I need to take an antibiotic while I am on Protear?

A: Official regulatory warnings advise caution when taking antibiotics, particularly due to the potential risk of Clostridium difficile-associated diarrhea (CDAD) when using acid-suppressing medicines. Specific antibiotics may also have known drug interactions that warrant professional review.

Q: Does Protear have a known risk of dependence or withdrawal symptoms?

A: Regulatory documents do not classify this drug as having a risk for addiction or dependence. However, prolonged use followed by abrupt discontinuation may lead to rebound acid hypersecretion, meaning a temporary worsening of heartburn symptoms.

Q: Can I take Protear if I have a history of heart problems?

A: Regulatory warnings caution against the co-administration of this medicine with certain antiplatelet medications, such as clopidogrel, due to a documented interaction. This should be reviewed by a prescribing professional.

Q: Does Protear interact with common supplements like Vitamin D or magnesium?

A: Regulatory documents warn that long-term use of this medicine (typically over a year) may lead to low serum magnesium levels (Hypomagnesemia). For this reason, medical professionals may advise monitoring or recommend magnesium supplementation during extended treatment.

Q: Can taking Protear affect the results of other medical tests?

A: Official labels state the drug may interfere with tests for neuroendocrine tumors (Chromogranin A or CgA) and certain urine tests. Patients are generally advised to inform testing personnel of their medication use.

Q: Where can I find the official regulatory information about Protear?

A: Official regulatory documents, such as the FDA-approved labeling and the NIH DailyMed database, are reliable, publicly accessible government sources that provide comprehensive drug information.

Q: Is Protear used for any conditions other than the main one it treats?

A: Yes, the regulatory label lists multiple approved uses for the medication. These include the treatment of stomach ulcers, healing of erosive esophagitis, relief of symptomatic GERD (gastroesophageal reflux disease), and management of pathological hypersecretory conditions.

Q: Is it normal to feel slightly dizzy after starting Protear?

A: Dizziness is listed as an uncommon adverse reaction in the official regulatory documents. If this or any other unusual reaction occurs, it is noted that these should be addressed by a healthcare provider.

Q: Does Protear have a black box warning?

A: The official FDA label contains a specific section dedicated to whether a drug carries a Boxed Warning (the most severe warning). This section clarifies the regulatory status of the medication.

Q: What does the patient information leaflet say about stopping Protear?

A: The official patient labeling provides guidance that the medicine should be discontinued only under the direction of a qualified healthcare provider. This is important because stopping treatment can sometimes lead to the temporary return of symptoms.

Q: Does Protear interfere with hormonal birth control?

A: Official drug interaction reports typically state that there is no known clinically significant pharmacokinetic interaction between this drug and oral contraceptives.

Q: Is Protear available over-the-counter in any country?

A: Regulatory bodies classify drug products as prescription or over-the-counter (OTC). In the United States, a version of this drug is available for purchase without a prescription.

Q: Can I consume alcohol in moderation while taking Protear?

A: Official regulatory labels generally do not list a specific interaction between the drug itself and alcohol. However, alcohol consumption may worsen the symptoms of the condition for which the medicine is being taken.

Q: Are there different brand names for the medicine Protear?

A: Yes, this medication is marketed under several different brand names (e.g., Prilosec) in addition to being available as a generic formulation.

Q: What official body approved Protear for use?

A: The medicine is approved for use by national regulatory authorities. In the United States, this approval came from the U.S. Food and Drug Administration (FDA); in Europe, it would be the European Medicines Agency (EMA).

Q: How soon after stopping Protear does it leave the body?

A: The regulatory pharmacokinetic data shows that the drug itself has a short elimination half-life, meaning it is quickly processed by the body. However, its therapeutic effect persists longer because it creates an irreversible blockade of the target enzyme system.

Q: Can I take Protear if I have high blood pressure?

A: High blood pressure is not listed as a contraindication in regulatory documents. However, some post-marketing surveillance reports have noted elevated blood pressure as a very rare potential adverse effect.

How should Protear be stored and disposed of?

The official regulatory requirements for this medicine mandate specific conditions to maintain product stability and safety.

Required Storage Environment

The product must be stored at a controlled room temperature, typically defined as 20 C to 25 C (68 F to 77 F), with temporary excursions permitted. It is mandatory to protect the capsules from moisture and light and to prevent the temperature from exceeding 30 C.

Packaging and Child Safety

To maintain the product's integrity, it must be kept in a tight container and tightly closed at all times. All regulatory labeling explicitly requires that the medicine be stored out of the reach and sight of children.

Disposal of Unused Medicine

Unused or expired medicine should not be flushed down the toilet or thrown into wastewater. Disposal must follow general guidance, which recommends either utilizing an approved drug take-back program or mixing the product with an undesirable substance before discarding it in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Protear found in:

A-Z Index: